knowlabs.co - רווח נקי למניה ב-12 החודשים האחרונים USBC

This price chart helps assess the lack of market influence on USBC Inc (USBC) during the development stage, where the indicator stands at 96.10. USBC Inc (USBC) is developing non-invasive sensors for diabetics, offering an alternative to painful injections. The business is currently focused on intensive preparation for FDA audits, seeking to confirm the flawless accuracy of its Bio-RFID radio-frequency system for mass adoption.

This indicator measures the rate of change in net income per share over a rolling year, capturing the actual cash return of the business. By analyzing the historical annual dynamics of EPS TTM for USBC Inc (USBC), an investor assesses the effectiveness of Bio-RFID sensor commercialization and patent scaling. Sharp fluctuations in the curve signal creditworthiness risks amid high R&D expenditures. Steady growth in this metric confirms the company's transition from development to profitable global expansion.